Execution issues worsen an already difficult situation, more pain in the offing
02/11/26 -"Alstom’s preliminary H1 results dealt a significant blow to remaining hopes of a revival under the new CEO. Execution issues on the Coradia Max platform affected sales growth and materially ..."
Pages
49
Language
English
Published on
02/11/26
You may also be interested by these reports :
16/11/26
Our EPS estimates have been revised following a change in the analyst covering the stock
16/11/26
Interroll (ADD; Switzerland) is often viewed as a cyclical supplier of rollers, drives and conveyors, dependent on customers’ willingness to invest ...
16/11/26
We raise our target price by c.12%, supported by significant upgrades to our DCF and NAV per share. With an order book of €164bn, the group’s equity ...
13/11/26
We raise our target price by c.12%, underpinned by a strong upgrade to our DCF per share and complemented by a 10% increase in our NAV calculation. ...